Cardiac Devices Emerge as the Strongest Predictor of Metastatic Candida auris Infection
Metastatic infection in Candidozyma auris candidemia did not track with age, prior candidemia, or recent surgery in this Spanish analysis. The signal instead clustered around intravascular hardware and prosthetic material, where a cardiac device or prosthetic valve carried a higher subdistribution hazard for metastatic spread.
The finding matters because C. auris is already a pathogen defined by persistence, healthcare transmission, and difficult treatment decisions. Once bloodstream infection is established, the clinical question shifts fast: who is likely to seed distant sites, and who needs a more aggressive search for occult complications? The model in this cohort points toward prosthetic cardiac material as the most visible risk marker.
The Multivariable Model Narrowed the Risk Signal
The analysis used multivariable Fine–Gray competing risks regression in patients with Candidozyma auris candidemia in Spain from 2016 to 2024. Four covariates were included in the table: previous candidemia, age per year, recent surgery, and cardiac device or prosthetic valve. Only the cardiac hardware variable reached statistical significance.
The subdistribution hazard ratio for cardiac device/prosthetic valve was 2.89, with a 95% confidence interval of 1.21 to 6.91 and a p value of 0.017. By contrast, previous candidemia carried an sHR of 1.61 with a wide confidence interval of 0.54 to 4.79 and a p value of 0.412. Age showed an sHR of 1.02 per year, with a 95% confidence interval of 0.99 to 1.05 and a p value of 0.241. Recent surgery had an sHR of 0.79, a 95% confidence interval of 0.33 to 1.90, and a p value of 0.603.
The pattern is clinically straightforward. Bloodstream infection alone does not explain metastatic seeding; foreign material appears to create a permissive surface where fungal adherence, biofilm formation, and incomplete clearance can turn a transient fungemia into a deeper, more durable infection. Prosthetic valves and implanted devices are especially relevant because they can shelter organisms from host immunity and antifungal exposure alike.
Why Prosthetic Material Changes the Biology of Candidemia
Fungal bloodstream infection behaves differently when a synthetic surface is involved. Organisms can anchor to hardware, build biofilm, and maintain a protected niche that is harder to sterilize than native tissue infection. In a candidemia setting, that biology increases concern for endocarditis, device infection, and hematogenous dissemination to other organs.
For C. auris, the concern is amplified by the organism’s well-known adaptability in healthcare environments and its ability to persist under pressure from both host defenses and infection-control barriers. A prosthetic valve or cardiac device may therefore function not just as a passive marker of illness severity, but as an active biologic platform for metastatic spread.
The table does not show a role for age. Older patients were not at significantly higher risk in this model, despite the intuitive expectation that age might track with frailty and more extensive comorbidity. The lack of association with recent surgery is also notable, because postoperative bloodstream infections often raise immediate concern for secondary foci. Here, the stronger signal came from implanted cardiac material rather than the recent operative state itself.
What the Confidence Intervals and P Values Actually Mean at the Bedside
The confidence interval around the cardiac-device estimate stayed entirely above 1.0, which makes the association difficult to dismiss as random noise within this dataset. The other three variables crossed 1.0 and remained nonsignificant, so they did not separate patients with metastatic infection from those without it in this model.
For bedside management, the message is not that every patient with C. auris candidemia and a valve prosthesis has metastatic disease. The message is narrower and more useful: prosthetic cardiac material should raise the threshold for complacency. Echocardiography, repeated blood-culture surveillance, and a low threshold for evaluating symptoms compatible with distant seeding become more important when hardware is present.
One sentence captures the clinical consequence: implanted cardiac material was the only variable in this table that clearly moved the risk estimate upward.
That finding also fits with the practical limitations of fungal bloodstream clearance. When the organism can persist on a device, microbiologic sterilization becomes harder, antifungal therapy may be less effective against a biofilm reservoir, and the probability of relapse or occult spread rises.
What This Table Does Not Prove
This table does not establish causality, and it does not tell clinicians how many patients had metastatic infection overall. It also does not provide the full clinical phenotype of those metastatic events, nor does it identify which organ systems were involved. The evidence here is associative, not mechanistic proof, even if the biology makes the result plausible.
The table is also limited by the variables included. Other contributors to metastatic spread may exist outside this four-variable model, including details of source control, the timing of antifungal therapy, species-level strain behavior, or the intensity of diagnostic workup. None of those elements appear in the table, so they cannot be inferred from it.
Even with those limits, the practical message is hard to ignore. In patients with Candidozyma auris candidemia, prosthetic valves and cardiac devices deserve immediate attention because they identify a subgroup with a materially higher risk of metastatic infection. For clinicians managing these cases, the threshold for looking beyond the bloodstream should be lower when foreign cardiac material is present, and the search should be guided by the very mechanism that makes these infections hard to clear in the first place: biofilm on implanted hardware.